| 标题 |
Safety and clinical outcomes of a first-in-human trial of point-of-care manufactured trispecific CAR T cells targeting CD19, CD20, and CD22 |
| 网址 | |
| DOI |
10.1158/2643-3230.bcd-26-0186
doi
|
| 其它 |
期刊:Blood cancer discovery 作者:Sumithira Vasu; Nathan Denlinger; No-Joon Song; Danielle Elsberry; Qiuhong Zhao; et al 出版日期:2026-07-14 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)